Matthew Myntti
Founder at NEXT SCIENCE LIMITED
Net worth: 2 M $ as of 2024-03-30
Profile
Matthew Myntti is the founder of Next Science Ltd.
which was founded in 2017, where he holds the title of Chief Technology Officer.
He is currently a Director at Microbial Defense System Holdings, Inc. since 2012.
He previously worked at Synthes GmbH as the President-Asia Pacific.
Dr. Myntti received his undergraduate and doctorate degrees from the University of Dayton.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXT SCIENCE LTD
3.59% | 2023-03-13 | 10,472,969 ( 3.59% ) | 2 M $ | 2024-03-30 |
Matthew Myntti active positions
| Companies | Position | Start |
|---|---|---|
| NEXT SCIENCE LIMITED | Founder | 2017-10-19 |
Microbial Defense System Holdings, Inc.
 Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Director/Board Member | 2012-03-29 |
Former positions of Matthew Myntti
| Companies | Position | End |
|---|---|---|
Synthes GmbH
 Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Corporate Officer/Principal | - |
Training of Matthew Myntti
| University of Dayton | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEXT SCIENCE LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Health Technology |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Finance |
- Stock Market
- Insiders
- Matthew Myntti
